4.10.25Segment

Rheumatology

Rheumatology practices and management organizations treating inflammatory arthritis, lupus, and autoimmune musculoskeletal conditions.

5
Verticals

Overview

Rheumatology practices and management organizations treat inflammatory arthritis, lupus, and autoimmune musculoskeletal conditions. The specialty's economics are increasingly tied to in-office biologic infusion, which provides significant ancillary revenue and has drawn private-equity interest.

Demand is supported by the prevalence of autoimmune and inflammatory conditions and the growth of biologic therapies, against a shortage of rheumatologists. Infusion-driven economics and emerging MSO consolidation define the investment thesis.

Market snapshot

FragmentationConsolidating

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so rheumatology is not separately sized.

Business model & economics

Revenue model
Office reimbursement plus in-office biologic infusion margin
Recurring revenue
High — chronic autoimmune care and infusion
EBITDA margin
18–28% with infusion ancillaries
Capex intensity
Low
  • In-office biologic infusion drives ancillary economics.
  • Autoimmune prevalence and biologics growth.
  • Rheumatologist shortage and emerging MSO interest.

M&A deal context

Moderate deal activity

Who’s acquiring

Infusion-focused MSO platformsPE-backed rheumatology consolidatorsMultispecialty acquirers

What’s driving deals

  • Roll-up for infusion ancillary economics.
  • Autoimmune and biologics demand.
  • Rheumatologist shortage.

Verticals in this segment

  • 4.10.25.1General Rheumatology Practices

    Independent rheumatology practices treating inflammatory and autoimmune conditions.

  • 4.10.25.2Infusion Therapy for Rheumatology

    Infusion centers delivering biologic infusions for rheumatologic conditions.

  • 4.10.25.3Pediatric Rheumatology Programs

    Specialists treating juvenile arthritis and pediatric autoimmune conditions.

  • 4.10.25.4Rheumatology & Musculoskeletal Centers

    Multi-disciplinary centers treating arthritis and MSK conditions.

  • 4.10.25.5Rheumatology Management Organizations

    PE-backed platforms consolidating rheumatology practices.

Find Rheumatology acquisition targets

Search Acquisera’s index for companies classified under Rheumatology (4.10.25) and build a targeted deal pipeline.

Search companies